000 | 01931 a2200529 4500 | ||
---|---|---|---|
005 | 20250518043255.0 | ||
264 | 0 | _c20200128 | |
008 | 202001s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2019.109052 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYang, Jing | |
245 | 0 | 0 |
_aHuman umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cSep 2019 |
||
300 |
_a109052 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAcute Disease |
650 | 0 | 4 |
_aAngiotensin II _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCulture Media, Conditioned _xpharmacology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMesenchymal Stem Cell Transplantation |
650 | 0 | 4 |
_aMesenchymal Stem Cells _xcytology |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 |
_aPancreas _xdrug effects |
650 | 0 | 4 |
_aPancreatitis _xpathology |
650 | 0 | 4 |
_aParacrine Communication _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aUmbilical Cord _xcytology |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xmetabolism |
700 | 1 | _aSu, Jun | |
700 | 1 | _aXi, Shao-Song | |
700 | 1 | _aKe, Xian-Fu | |
700 | 1 | _aZhu, Ying | |
700 | 1 | _aLin, Hua-Peng | |
700 | 1 | _aZeng, Xiao-Kang | |
700 | 1 | _aLiu, Bing-Wei | |
700 | 1 | _aZhu, Ming-Li | |
700 | 1 | _aDai, Wei-Ying | |
700 | 1 | _aHu, Wei | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 117 _gp. 109052 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2019.109052 _zAvailable from publisher's website |
999 |
_c29775982 _d29775982 |